TSE:MBX Microbix Biosystems (MBX) Stock Price, News & Analysis C$0.29 -0.01 (-1.69%) As of 03:42 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock About Microbix Biosystems Stock (TSE:MBX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Microbix Biosystems alerts:Sign Up Key Stats Today's RangeC$0.29▼C$0.3150-Day RangeC$0.29▼C$0.3752-Week RangeC$0.28▼C$0.55Volume33,873 shsAverage Volume129,763 shsMarket CapitalizationC$38.19 millionP/E Ratio11.05Dividend Yield2.30%Price TargetN/AConsensus RatingN/A Company Overview Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada. Read More Receive MBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter. Email Address MBX Stock News HeadlinesMicrobix & Bulgaria’s NCIPD Execute Supply AgreementJuly 8, 2025 | financialpost.comFMicrobix Biosystems Inc. (MBX.TO) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.July 18 at 2:00 AM | Stansberry Research (Ad)Microbix Showcases Diagnostic Innovations at Asia Pacific ConferenceJune 17, 2025 | tipranks.comMicrobix Reports Results for Q2 Fiscal 2025May 15, 2025 | financialpost.comFMicrobix Reports Results for Q2 Fiscal 2025May 15, 2025 | financialpost.comFMicrobix & Aurevia Introduce Novel EQA SchemeMay 13, 2025 | finance.yahoo.comMicrobix Schedules Release of Results for Q2 Fiscal 2025May 8, 2025 | finance.yahoo.comSee More Headlines MBX Stock Analysis - Frequently Asked Questions How have MBX shares performed this year? Microbix Biosystems' stock was trading at C$0.41 at the beginning of 2025. Since then, MBX shares have decreased by 29.3% and is now trading at C$0.29. How do I buy shares of Microbix Biosystems? Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Microbix Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Microbix Biosystems investors own include TransAlta Renewables (RNW), Moderna (MRNA), Canopy Growth (CGC), NightHawk Biosciences (NHWK), Organigram (OGI), VEON (VEON) and Vaxart (VXRT). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:MBX CIKN/A Webmicrobix.com Phone+1-905-3618910FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C$0.03 Trailing P/E Ratio11.24 Forward P/E Ratio14.75 P/E GrowthN/ANet IncomeC$3.39 million Net Margins13.86% Pretax MarginN/A Return on Equity12.65% Return on Assets3.82% Debt Debt-to-Equity Ratio22.61 Current Ratio7.15 Quick Ratio5.57 Sales & Book Value Annual SalesC$24.42 million Price / Sales1.59 Cash FlowC$0.07 per share Price / Cash Flow4.13 Book ValueC$0.21 per share Price / Book1.43Miscellaneous Outstanding Shares131,704,278Free FloatN/AMarket CapC$38.85 million OptionableNot Optionable Beta0.34 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (TSE:MBX) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbix Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.